Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. However, more highly innovative/high-cost treatments, within infectious disease and neurology space, are likely to enter the market for rare disorders, increasing the number of non-oncology RSAs.

FDA 105

FDA 105

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Communication 94

Communication Insurance Packaging Pharmaceutical Companies 94

pharmaphorum

JUNE 8, 2021

Biogen chef executive Michel Vounatsos defended Aduhelm in an open letter on the company’s website, saying that the company has “engaged extensively with health economists, public health experts, and payers about Aduhelm – and we have examined other recent biologic drug innovations.”

FDA 98

FDA Labelling 98

pharmaphorum

AUGUST 28, 2020

The world is awash with data, and while retailers and TV subscription services have perfected the art of collection and curation, public health has been trailing behind. Prof Brownstein, who is also chief innovation officer at Boston Children’s Hospital, said: “COVID-19 has put a real focus on the inadequacies of public health.

Hospitals 66

Hospitals 66

pharmaphorum

AUGUST 18, 2022

million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 The company said it would give a treatment guarantee with the product, offering to reimburse health insurers up to 80% of the cost if Zynteglo stops working in the two years after it is administered.

FDA 52

FDA Insurance 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics). LinkedIn Total experience: 35 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

pharmaphorum

DECEMBER 2, 2020

As a consequence of Pfizer’s innovation, the price of citric acid tumbled over the succeeding decades, with the value of the chemical falling by 5/6ths in 20 years. In 2017/2018 Pfizer attempted to sell its consumer health unit, but buyers including Proctor & Gamble and GSK pulled out of negotiations.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. But he’s clear that the templated approach required by modular content needn’t stifle innovation. “We’re We’re all trying to find ways to automate.

Communication 97

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 97

pharmaphorum

NOVEMBER 16, 2022

Of the innovations that have happened recently in pharma drug development, it is cell and gene therapy that have received the most attention. However, with a price tag of €1.58 However, a recently released report from the organisation could blow the price tag of Zolgensma out of the water. How to navigate the new climate.

131

131

pharmaphorum

JUNE 15, 2021

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways and public-private partnerships drive innovation to address a common need. A new economic reality is challenging profitability .

Vaccines 90

Vaccines 90

pharmaphorum

NOVEMBER 28, 2022

Innovation thrives in collaboration, not in isolation – and the open sourcing of Substra is a landmark moment in the use of collaborative AI in medical research,” Ibrahim Haddad, general manager of the LF AI & Data Foundation, said in a statement.

Hospitals 72

Hospitals 72

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

Documentation 52

Documentation Immunization Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

SEPTEMBER 14, 2023

Discover the innovative approaches that pharma brands employ to effectively address challenges and drive progress. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags. Digital Transformation in Pharma Procurement It is no secret that the coronavirus hit the health sectors the hardest.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

European Pharmaceutical Review

MAY 11, 2023

3 The one-time gene therapy received final draft guidance from the National Institute for Health and Care Excellence (NICE) on 16 March 2023. We’ve learnt that innovative therapies, like Zolgensma, require equally inventive access pathways so that as many patients as possible benefit from treatment. Why is it significant?

FDA 68

FDA 68

pharmaphorum

FEBRUARY 26, 2021

Between 1896 and 1897, J&J enabled a huge step forward for women’s health when it manufactured the first mass-produced sanitary protection products. Its founder, Dr Paul Janssen, is recognised as one of the most innovative and prolific pharmaceutical researchers of the 20th century.

Vaccines 126

Vaccines Labelling Communication 126

Viseven

FEBRUARY 6, 2023

Key healthcare marketing trends that organizations should follow in 2023 Understandably, marketers must constantly stay informed about the latest trends and innovations that can change the industry. In this article, we decided to list some of the most prominent healthcare marketing trends to follow in 2023.

Communication 75

Communication 75

Pharmaceutical Technology

MARCH 17, 2023

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) defines risk sharing agreements as “an arrangement between a manufacturer and payer/provider that enables access to (coverage/reimbursement of) a health technology subject to specified conditions”. Click here to watch this webinar and access the presentation.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% The UK and US are both undergoing an obesity crisis.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% The UK and US are both undergoing an obesity crisis.

Insurance 98

Insurance Labelling Communication FDA 98